(Q45917628)

17 December 2017

title

Delayed seizure associated with paclitaxel-Cremophor el in a patient with early-stage breast cancer. (English)

1 reference

17 December 2017

1 reference

Tracey L O'Connor

1

1 reference

17 December 2017

Ellen Kossoff

series ordinal

2

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

17 December 2017

published in

Pharmacotherapy

1 reference

17 December 2017

volume

29

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

page(s)

993-996

1 reference

17 December 2017

Paclitaxel chemotherapy: from empiricism to a mechanism-based formulation strategy

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.993

Case report of a generalized seizure related to Paclitaxel infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.993

Transient encephalopathy after paclitaxel (Taxol) infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.993

Inter-relationships of paclitaxel disposition, infusion duration and cremophor EL kinetics in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.993

Pharmacodynamics of non-break weekly paclitaxel (Taxol) and pharmacokinetics of Cremophor-EL vehicle: results of a dose-escalation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.993

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.993

Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.8.993

21 January 2018

Identifiers

DOI

10.1592/PHCO.29.8.993

1 reference

17 December 2017

1 reference

17 December 2017